Guangdong Zhongsheng Pharmaceutical (002317) Stock Price, News, Quotes-Moomoo

CN Stock MarketDetailed Quotes

002317 Guangdong Zhongsheng Pharmaceutical

Watchlist

11.40
+0.01+0.09%

Market Closed Jan 17 15:00 CST

9.71BMarket Cap73.08P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Individual Investors Among Guangdong Zhongsheng Pharmaceutical Co., Ltd.'s (SZSE:002317) Largest Stockholders and Were Hit After Last Week's 3.6% Price Drop
Simply Wall StDec 30, 2024 18:00 ET
Zhongsheng Pharmaceutical's Unit Gets Nod to Increase Specifications of Mucus Regulator Drug
MT NewswiresNov 11, 2024 02:26 ET
Guangdong Zhongsheng Pharmaceutical Co., Ltd.'s (SZSE:002317) Stock Has Shown A Decent Performance: Have Financials A Role To Play?
Simply Wall StOct 31, 2024 20:23 ET
Guangdong Zhongsheng Pharmaceutical (SZSE:002317) Shareholder Returns Have Been Favorable, Earning 45% in 3 Years
Simply Wall StOct 2, 2024 21:54 ET
Some May Be Optimistic About Guangdong Zhongsheng Pharmaceutical's (SZSE:002317) Earnings
Simply Wall StSep 5, 2024 18:20 ET
Guangdong Zhongsheng Pharmaceutical Co., Ltd.'s (SZSE:002317) 8.8% Gain Last Week Benefited Both Individual Investors Who Own 55% as Well as Insiders
Simply Wall StAug 12, 2024 19:26 ET

Comments

Moomoo AI

Mar 26, 2024 18:13

Despite a high P/E ratio and lower forecast growth, many investors are holding onto their stock, potentially setting up for future disappointment. The high P/E and predicted earnings do not support such positive sentiment for long.

Guangdong Zhongsheng Pharmaceutical Co., Ltd. (SZSE:002317) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected

Moomoo AI

Jan 22, 2024 02:02

Despite strong earnings growth, the company's high P/E ratio may lead to future disappointment if it falls to align with recent growth rates. The current P/E ratio may not sustain positive sentiment unless medium-term conditions improve.